Cosmos Health’s C-Sept PRO Gains Strong Traction Across Leading Greek Public and Private Hospital Groups, With Annualized Sales Poised to Exceed $1.3 Million at Approximately 72% Gross Margin
Cosmos Health Inc. reports accelerating sales of its antiseptic product C-Sept PRO across major public and private hospital groups in Greece, achieving over $1.3 million in projected annual sales and a gross margin of approximately 72%. The product is widely adopted due to its efficacy and recurring demand in hospital infection control. The company…